Form 4: Revolution Medicines CFO Exercises Options and Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Revolution Medicines' CFO, Jack Anders, exercised stock options and sold shares on May 3, 2024, under a pre-arranged 10b5-1 trading plan.
Summary
- On May 3, 2024, Jack Anders, the Chief Financial Officer of Revolution Medicines, exercised stock options to acquire 10,000 shares of common stock at a price of $2.68 per share.
- Simultaneously, Anders sold 10,000 shares of common stock at a weighted average price of $40.026 per share, with individual sales prices ranging from $40.00 to $40.13.
- These transactions were executed under a pre-existing 10b5-1 trading plan adopted by Anders on March 27, 2023.
- Following these transactions, Anders directly owns 101,959 shares of Revolution Medicines common stock, which includes 60,250 restricted stock units, and 12,814 stock options.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it is a routine disclosure of insider transactions under a pre-arranged trading plan. There is no indication of positive or negative implications for the company.
Industry Context
This filing is a routine disclosure of insider transactions and is common for executives who have stock-based compensation. The use of a 10b5-1 plan indicates that the transactions were pre-planned to avoid accusations of insider trading.
Key Dates
| Date | Description |
|---|---|
| 03/27/2023 | Date the Reporting Person adopted the 10b5-1 trading plan |
| 08/16/2022 | Date the Stock Options were exercisable |
| 05/03/2024 | Date of the stock option exercise and share sale |
| 09/26/2028 | Expiration date of the Stock Options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.